ZA200109334B - Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance. - Google Patents

Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance.

Info

Publication number
ZA200109334B
ZA200109334B ZA200109334A ZA200109334A ZA200109334B ZA 200109334 B ZA200109334 B ZA 200109334B ZA 200109334 A ZA200109334 A ZA 200109334A ZA 200109334 A ZA200109334 A ZA 200109334A ZA 200109334 B ZA200109334 B ZA 200109334B
Authority
ZA
South Africa
Prior art keywords
drugs
overcoming
anticancer
carcinostatic
tolerance
Prior art date
Application number
ZA200109334A
Other languages
English (en)
Inventor
Noboru Kaneko
Kazuhito Nishio
Takashi Nakamura
Original Assignee
Noboru Kaneko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noboru Kaneko filed Critical Noboru Kaneko
Publication of ZA200109334B publication Critical patent/ZA200109334B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200109334A 1999-05-19 2001-11-13 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance. ZA200109334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13919699 1999-05-19

Publications (1)

Publication Number Publication Date
ZA200109334B true ZA200109334B (en) 2003-01-29

Family

ID=15239803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109334A ZA200109334B (en) 1999-05-19 2001-11-13 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance.

Country Status (12)

Country Link
US (1) US6977252B1 (ko)
EP (1) EP1184037B1 (ko)
KR (1) KR100686617B1 (ko)
CN (1) CN1178663C (ko)
AT (1) ATE298575T1 (ko)
AU (1) AU774656B2 (ko)
CA (1) CA2373484C (ko)
DE (1) DE60021075T2 (ko)
NO (1) NO20015600L (ko)
TW (1) TWI221093B (ko)
WO (1) WO2000071132A1 (ko)
ZA (1) ZA200109334B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
CN1311818C (zh) * 2004-11-22 2007-04-25 山东蓝金生物工程有限公司 一种抗实体肿瘤的药物组合物
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
WO2009148623A2 (en) * 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer
US10071996B2 (en) 2014-07-30 2018-09-11 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
KR102440098B1 (ko) * 2020-07-31 2022-09-05 부산대학교 산학협력단 Agr2의 동종이량체를 표적으로 하는 저분자 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS579712A (en) * 1980-06-20 1982-01-19 Fukumi Morishige Instilling (dripping) liquid for intravenous injection
JP2703408B2 (ja) 1990-12-28 1998-01-26 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
JP3093419B2 (ja) 1992-03-30 2000-10-03 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
US5643909A (en) 1993-04-19 1997-07-01 Syntex (U.S.A.) Inc. 10,11-Methanodibenzosuberane derivatives
US5700826A (en) 1995-06-07 1997-12-23 Ontogen Corporation 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
JP4063964B2 (ja) 1998-08-12 2008-03-19 金子 昇 神経細胞保護薬

Also Published As

Publication number Publication date
EP1184037A1 (en) 2002-03-06
AU774656B2 (en) 2004-07-01
DE60021075T2 (de) 2006-05-24
EP1184037B1 (en) 2005-06-29
DE60021075D1 (de) 2005-08-04
NO20015600L (no) 2001-12-20
TWI221093B (en) 2004-09-21
KR20020008407A (ko) 2002-01-30
US6977252B1 (en) 2005-12-20
ATE298575T1 (de) 2005-07-15
NO20015600D0 (no) 2001-11-16
CN1361693A (zh) 2002-07-31
KR100686617B1 (ko) 2007-02-23
AU4778300A (en) 2000-12-12
EP1184037A4 (en) 2003-12-03
CA2373484C (en) 2009-01-20
CA2373484A1 (en) 2000-11-30
CN1178663C (zh) 2004-12-08
WO2000071132A1 (fr) 2000-11-30

Similar Documents

Publication Publication Date Title
NO20024424D0 (no) Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
HK1107814A1 (en) Thiadiazoline derivatives for treating cancer
EP1092435A4 (en) ANTIDIABETIC DRUGS
ZA200109334B (en) Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance.
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
ATE223411T1 (de) 1-methylcarbapenem-derivate
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
ATE134376T1 (de) Mono- und bis-alkylaminoanthracycline
WO2000010543A3 (de) Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
DE60238847D1 (de) Pyrimidinderivate enthaltendes medikament
DE69919191D1 (de) Heilmittel für die stenose des rückenmarkkanals
ATE122892T1 (de) Zusammensetzung gegen katarakt.
BR0108448A (pt) Derivados de tetraidrofuril óxi-e amino-substituìdos com atividade antitumor
NO20010244L (no) Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene
TH36111A (th) อนุพันธ์ไพแรโซล
TH58173A3 (th) อนุพันธ์ 4,4-ไบเอริลพิเพอริดิน